Re:Alterations in glutamate and the experience of ego dissol...
by PragmaticPulp on Thursday May 28, 2020 @12:15PM
(#23339020)
> The process that patients go through when participating in a medical trial of psilocybin is so different than the typical recreational setting that the rest of us experience these drugs. They do everything they can to make sure the patient is well prepared and has the minimum chance of having a bad trip.
Not just this, but they surround the sessions with intense therapy.
They're not just giving people psychedelics and keeping them calm. Look up the MAPS (a foundation for psychedelic research) protocol. People are given a series of intense therapy sessions, only some of which involve psychedelics.
Sadly, many of the studies fail to have an active control group. That is, they aren't comparing therapy + psychedelics to therapy alone. That's a major pitfall in the current research.
And unfortunately, the therapy component of the research is lost in most internet headlines and articles. People are walking away with the impression that psychedelics are inherently anti-depressant compounds, when the reality is that they're being researched as adjuncts to intense therapy.
Not just this, but they surround the sessions with intense therapy.
They're not just giving people psychedelics and keeping them calm. Look up the MAPS (a foundation for psychedelic research) protocol. People are given a series of intense therapy sessions, only some of which involve psychedelics.
Sadly, many of the studies fail to have an active control group. That is, they aren't comparing therapy + psychedelics to therapy alone. That's a major pitfall in the current research.
And unfortunately, the therapy component of the research is lost in most internet headlines and articles. People are walking away with the impression that psychedelics are inherently anti-depressant compounds, when the reality is that they're being researched as adjuncts to intense therapy.